Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Methods for Inducing Differentiation of a Cell Using Phenyacetic Acid and Derivatives

  • Read more about Methods for Inducing Differentiation of a Cell Using Phenyacetic Acid and Derivatives
US Patent 5,635,533
Filed on 1995-06-06

COMPOSITION AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER, AIDS AND ANEMIA

  • Read more about COMPOSITION AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER, AIDS AND ANEMIA
US Patent 5,654,333
Filed on 1995-06-06

COMPOSITION AND METHODS FOR TREATING AND PREVENTING PATHOLOGIES INCLUDING CANCER

  • Read more about COMPOSITION AND METHODS FOR TREATING AND PREVENTING PATHOLOGIES INCLUDING CANCER
US Patent 5,843,994
Filed on 1995-06-07

Methods of Characterizing Ligands for the erbB-3 Receptor, Methods of Influencing erbB-3 Activities and Methods of Diagnosing erbB-3-Related Neoplasm

  • Read more about Methods of Characterizing Ligands for the erbB-3 Receptor, Methods of Influencing erbB-3 Activities and Methods of Diagnosing erbB-3-Related Neoplasm
US Patent 5,916,755
Filed on 1995-06-07

Method of Targeting a Therapeutic Agent to Cells Expressing the erbB-3 Receptor

  • Read more about Method of Targeting a Therapeutic Agent to Cells Expressing the erbB-3 Receptor
US Patent 5,820,859
Filed on 1995-06-07

Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

  • Read more about Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
US Patent 6,653,084
Filed on 1995-06-07

HUMAN GENE RELATED TO BUT DISTINCT FROM EGF RECEPTOR GENE (erbB-2)

  • Read more about HUMAN GENE RELATED TO BUT DISTINCT FROM EGF RECEPTOR GENE (erbB-2)
US Application 08/480,257
Filed on 1995-06-07

HUMAN GENE RELATED TO BUT DISTINCT FROM EGF RECEPTOR GENE (Antibody Therapy, including immunotoxin conjugates, methods only)

  • Read more about HUMAN GENE RELATED TO BUT DISTINCT FROM EGF RECEPTOR GENE (Antibody Therapy, including immunotoxin conjugates, methods only)
US Application 08/472,117
Filed on 1995-06-07

Human Gene Related To But Distinct From EGF Receptor Gene

  • Read more about Human Gene Related To But Distinct From EGF Receptor Gene
US Patent 5,985,553
Filed on 1995-06-07

VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE

  • Read more about VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
US Patent 5,759,790
Filed on 1995-06-05

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1568
  • Page 1569
  • Page 1570
  • Page 1571
  • Page 1572
  • Page 1573
  • Page 1574
  • Page 1575
  • Page 1576
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health